Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Qiongxuan Xie"'
Autor:
Hongpei Tan, Jiahao Liu, Jing Huang, Yanan Li, Qiongxuan Xie, Yuqian Dong, Ze Mi, Xiaoqian Ma, Pengfei Rong
Publikováno v:
Journal of Translational Medicine, Vol 21, Iss 1, Pp 1-16 (2023)
Abstract Background Great progress has been made in applying immunotherapy to the clinical treatment of tumors. However, many patients with triple-negative breast cancer (TNBC) cannot benefit from immunotherapy due to the immune desert type of TNBC,
Externí odkaz:
https://doaj.org/article/69cbb2f14264449d8a703c162775fbc7
Autor:
Qiongxuan Xie, Bin Xie, Ludi Ou, Min Wang, Ziqing Tang, Yuxiang He, Xiaoyu Yang, Jidong Hong, Zhiping Lyu, Rui Wei
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
ObjectiveCentral neurocytoma (CN) is a rare type of tumor that currently lacks an optimal treatment protocol. This study aimed to explore the clinical outcomes of CN in a cohort of 101 patients and identify prognostic factors associated with multiple
Externí odkaz:
https://doaj.org/article/35674766ada94d68a9a877b4a291e2e5
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Background: Esthesioneuroblastoma (ENB) is a rare sinonasal malignancy, lacking a unified staging system and treatment. Management at a single center was retrospectively evaluated to inform future treatment options and prognostic factors.Methods: Cli
Externí odkaz:
https://doaj.org/article/ebceca835cda4ddcb7427f20f4033589
Autor:
Yangqing Sun, Kaimei Cai, Changhao Huang, Xue Xia, Xueyan Chen, Qiongxuan Xie, Pei Liu, Y i Xu, Yihong He, Rui Wei, Zhengnan Ming, Qingqing Liu, Junli Luo
Publikováno v:
Acta Biochimica et Biophysica Sinica. 53:893-902
Pre-mRNA processing factor 19 (PRPF19) is a multifaceted protein and participates in DNA damage response and pre-mRNA processing. The role of PRPF19 in cancer is unclear. Here, we report that the expression of PRPF19 in human tongue cancer is associa
Autor:
Pei Liu, Gui Liu, Jidong Hong, Guihua Wang, Qian Zeng, Weibing Zhou, Qiongxuan Xie, Rui Wei, Yangqing Sun, Wen Chen, Ludi Ou
Publikováno v:
BioMed Research International, Vol 2020 (2020)
BioMed Research International
BioMed Research International
Purpose. Because of the poor prognosis for high-grade glioma (HGG) patients, it is important to increase the dose of the tumor to improve the efficacy while minimizing the dose of organs at risk (OARs). Thus, we evaluated the potential dosimetric gai